# Arbevel

> Arbevel is a VC fund in Paris backing Health Care, Medical and Biotechnology. See 18 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Paris, France
- Total investments: 18
- Last investment: Feb 2025
- Lead investor: 22%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/financi-re-arbevel/about/
- Website: https://www.arbevel.com/fr

Arbevel is an independent and entrepreneurial management company, Financière Arbevel has become a reference in the small and mid caps segment.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $6.5M–$18M |
| Series C | $14M–$47M |
| Debt Financing | $4.3M–$77M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 6 | 33% |
| Medical | 5 | 28% |
| Biotechnology | 3 | 17% |
| Medical Device | 2 | 11% |
| News | 1 | 6% |

31 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 22% |
| Series C | 3 | 17% |
| Debt Financing | 3 | 17% |
| Venture - Series Unknown | 3 | 17% |
| Series B | 2 | 11% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 12 | 67% |
| Israel | 1 | 6% |
| United States | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Germitec SAS | Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system. | $30.1M | Series B | Feb 12, 2025 |  |
| Karmen | Karmen offers non-dilutive financing solutions that enable digital businesses to access capital quickly and flexibly. The platform allows companies to secure funds for various needs, such as customer acquisition, recruitment, and inventory financing, with a streamlined online process. |  | Debt Financing | Jan 21, 2025 |  |
| UroMems | UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life. | $47.1M | Series C | Jun 25, 2024 |  |
| SoMeD Sante | SoMeD Santé is a private French health centre and management facilities group, providing dental, medical, paramedic and radiology care. | $4.3M | Debt Financing | Feb 09, 2024 |  |
| Kalray | KALRAY is a fabless semiconductor and software company that develops, markets & sells a new generation of manycore processors for Imaging, Telecommunication infrastructures, Data Security & Network Appliances embedded applications. | $25.7M | Post-IPO Equity | Dec 02, 2022 |  |
| Kalray | Kalray is an intelligent Data Processing from Cloud to Edge. | $26.8M |  | Dec 01, 2022 |  |
| Eovolt | Eovolt is a French brand that specializes in folding, lightweight, and ultra-compact electric bike. Eovolt bikes are ideal for motorhomes, boat owners or just for city-dwellers allowing them to travels easier enjoy cycling while optimizing your space. It was founded in 2018. | $16.2M | Venture - Series Unknown | Sep 12, 2022 |  |
| Germitec SAS | Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system. | $11.6M | Venture - Series Unknown | May 10, 2022 |  |
| MEXBRAIN | MexBrain is a biotechnology company based on extracting metals from the human body. They create medical equipment that can extract metals precisely, quickly, and under control. Additionally, they combine the two technologies of nanotechnology and dialysis. This increases the treatment's efficacy and enables everyone to benefit from bothworlds. | $6.9M | Series A | May 06, 2021 |  |
| UroMems | UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life. | $8.3M | Series B | Apr 06, 2021 |  |

10 of 18 investments shown.

## Co-investors
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 6 deals together
- [Supernova Invest](https://shizune.co/investors/profile/supernova-invest) — VC Fund, 4 deals together
- [Wellington Partners](https://shizune.co/investors/profile/wellington-partners) — VC Fund, 4 deals together
- [b2venture](https://shizune.co/investors/profile/btovpartners) — VC Fund, 3 deals together
- [Hil-Invent](https://shizune.co/investors/profile/hil-invent) — VC Fund, 3 deals together
- [Aquiline Capital Partners](https://shizune.co/investors/profile/aquiline-capital-partners) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Medical Investors in France](https://shizune.co/investors/medical-investors-france)
- [Medical VC Funds in France](https://shizune.co/investors/medical-vc-funds-france)

## FAQ

### What does Arbevel invest in?

Arbevel invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series C stage. Most of the 18 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Arbevel's check size?

Arbevel typically joins rounds of $6.5M–$18M at Series A, $14M–$47M at Series C and $4.3M–$77M at Debt Financing. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Arbevel participates in.

### When did Arbevel last invest?

The most recent investment recorded for Arbevel closed in Feb 2025. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co